Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Orynbayeva Zulfiya

From Bioblast


MiPsociety
News and Events        
BEC 2020.1 Mitochondrial physiology
       
MitoEAGLE
        Working Groups         Short-Term Scientific Missions         Management Committee         Members        
MitoGlobal
   


EU-logo.jpg

COST Action CA15203 (2016-2021): MitoEAGLE
Evolution-Age-Gender-Lifestyle-Environment: mitochondrial fitness mapping


Orynbayeva Zulfiya


MitoPedia topics: EAGLE 

COST: Member COST WG1: WG1


Name Orynbayeva Zulfiya, PhD ORCID ID
Institution
Zulfiya Orynbayeva
Zulfiya joined Oroboros Instruments from October 2020 to February 2021.
Address ,
City Warminster
State/Province Pennsylvania (PA)
Country USA
Email
Weblink
O2k-Network Lab AT Innsbruck Oroboros, US PA Philadelphia Orynbayeva Z



Bioenergetics Communications

Keywords: mitochondria, oncology, neurodegeneration

Participated

Labels:

Topics: Mitochondria, permeability transition, respiration, ROS system, cancer cell physiology 


Publications

 PublishedReference
BEC 2020.1 doi10.26124bec2020-0001.v1BEC 2020.1Gnaiger E et al โ€• MitoEAGLE Task Group (2020) Mitochondrial physiology. https://doi.org/10.26124/bec:2020-0001.v1
Gainutdinov 2022 MitoFit2022-08-16Gainutdinov T, Debska-Vielhaber G, Gizatullina Z, Vielhaber S, Orynbayeva Z, Gellerich FN (2022) Impaired Ca2+ signalling as an indicator of disturbed mitochondrial function in fibroblasts from patients with sporadic and familial ALS. https://doi.org/10.26124/mitofit:2022-0015.v2
Charles 2020 Nanomedicine (Lond)2020Charles C, Cohen-Erez I, Kazaoka B, Melnikov O, Stein DE, Sensenig R, Rapaport H, Orynbayeva Z (2020) Mitochondrial responses to organelle-specific drug delivering nanoparticles composed of polypeptide and peptide complexes. Nanomedicine (Lond) 15:2917-32.
Altinok 2019 J Cell Physiol2019Altinok O, Poggio JL, Stein DE, Bowne WB, Shieh AC, Snyder NW, Orynbayeva Z (2019) Malate-aspartate shuttle promotes l-lactate oxidation in mitochondria. J Cell Physiol 235:2569-81.
Nacarelli 2018 Geroscience2018Nacarelli T, Azar A, Altinok O, Orynbayeva Z, Sell C (2018) Rapamycin increases oxidative metabolism and enhances metabolic flexibility in human cardiac fibroblasts. Geroscience 40:243-56.
Irgebay 2017 Breast2017Irgebay Z, Yeszhan B, Sen B, Tuleukhanov S, Brooks AD, Sensenig R, Orynbayeva Z (2017) Danazol alters mitochondria metabolism of fibrocystic breast Mcf10A cells. Breast 35:55-62.
Zhunussova 2016 PLOS ONE2016Zhunussova A, Vitol EA, Polyak B, Tuleukhanov S, Brooks AD, Sensenig R, Friedman G, Orynbayeva Z (2016) Mitochondria-mediated anticancer effects of non-thermal atmospheric plasma. PLOS ONE 11:e0156818.
Orynbayeva 2015 Nanomedicine (Lond)2015Orynbayeva Z, Sensenig R, Polyak B (2015) Metabolic and structural integrity of magnetic nanoparticle-loaded primary endothelial cells for targeted cell therapy. Nanomedicine (Lond) 10:1555-68.
Gainutdinov 2015 Arch Biochem Biophys2015Gainutdinov T, Molkentin JD, Siemen D, Ziemer M, Debska-Vielhaber G, Vielhaber S, Gizatullina Z, Orynbayeva Z, Gellerich FN (2015) Knockout of cyclophilin D in Ppif(-/-) mice increases stability of brain mitochondria against Ca(2+) stress. Arch Biochem Biophys 579:40-6.
Zhunussova 2015 Am J Cancer Res2015Zhunussova A, Sen B, Friedman L, Tuleukhanov S, Brooks AD, Sensenig R, Orynbayeva Z (2015) Tumor microenvironment promotes dicarboxylic acid carrier-mediated transport of succinate to fuel prostate cancer mitochondria. Am J Cancer Res 5:1665-79.

Abstracts

 PublishedReference
Panov 2011 Abstract IOC652011Panov A, Orynbayeva Z (2011) The bioenergetic signature of prostate cancer. MiPNet16.03.